[Correlation between 4G and 5G genetypes distribution of plasminogen activator inhibitor-1 gene polymorphism in its promoter region with polycystic ovarian syndrome]

Zhonghua Fu Chan Ke Za Zhi. 2005 Aug;40(8):528-31.
[Article in Chinese]

Abstract

Objective: To investigate the correlation of 4G and 5G genetypes distribution of plasminogen activator inhibitor-1 (PAI-1) gene polymorphism in its promoter region with polycystic ovary syndrome (PCOS).

Methods: In 101 Chinese PCOS patients and 42 women as control, 4G and 5G polymorphisms of PAI-1 gene were detected with PCR-restriction fragment length polymorphism (RFLP). Pregnant history, body mass index (BMI), waist-hip ratio (WHR) were collected and Homastasis Model Assessment score for insulin resistant (Homa-IR) and insulin sensitive index (ISI) in PCOS groups were calculated.

Results: The distributions of PAI-1 gene polymorphisms 4G type (4G/4G genetype) and 5G type (5G/5G, 4G/5G genetype) were different between the PCOS group and the control. The PCOS group had higher 4G type 57% (58/101) distribution than that of the control group 38% (16/42); 5G type is vise verse (P < 0.05). PCOS patients were divided into obese and non-obese sub-groups according to BMI. There were significant lower Homa-IR and higher ISI in non-obese subgroup than that in obese group (P < 0.05; P < 0.01). 68% (36/53) 4G type distribution in the non-obese is higher than that [48% (23/48)] in obese sub-group (P < 0.05). There were higher 4G type distribution 79% (11/14) and lower 5G type distribution 21% (3/14) in spontaneous miscarriage group than that of in non-spontaneous miscarriage group 38% (5/13) and 62% (8/13) among patients who impregnated at least once (n = 27, P < 0.05).

Conclusion: PAI-1 gene polymorphism 4G genetype may be correlated with PCOS in Chinese women, especially in PCOS patients with non-obese PCOS and spontaneous miscarriage.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Glucose
  • Female
  • Gene Frequency
  • Genotype*
  • Humans
  • Insulin / metabolism
  • Obesity / genetics
  • Plasminogen Activator Inhibitor 1 / genetics*
  • Polycystic Ovary Syndrome / genetics*
  • Polymorphism, Genetic*
  • Polymorphism, Restriction Fragment Length
  • Statistics as Topic

Substances

  • Blood Glucose
  • Insulin
  • Plasminogen Activator Inhibitor 1